Pfizer said in a statement on Sunday that it will reduce its Massachusetts workforce by about 200 employees — almost 10 percent of its headcount in the state — as it ends development of drugs aimed at Alzheimer’s and Parkinson’s disease as well as other neuroscience research programs. The New York City-based pharmaceutical company (NYSE: PFE) said the total job cuts from the restructuring will be 300, about a third each in Cambridge, Andover and Groton, Connecticut.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News